pH News and Research

RSS

pH comes from the term “power of Hydrogen”, or the hydrogen ion concentration present in a given solution. It helps to measure the acidity or alkalinity of a substance.

Study explores sextortion prevalence behaviors among teens

According to the United States Department of Justice, "sextortion" is labeled as the most important and fastest-growing cyberthreat to children, with more minor victims per offender than all other child sexual exploitation offenses.

9 Oct 2018

Antibody Screening Tools; Improving Workflows

Antibody screening tools have exponentially increased the rate that candidates can be screened, multiplexing will increase processing to thousands per hour.¬

From Sartorius 9 Oct 2018

Celmatix partners with Oncotest-Teva to bring Fertilome test to Israel

Today, Celmatix, a next-generation women's health company, has announced a commercial agreement with Oncotest-Teva Ltd, a subsidiary of Teva Pharmaceutical Industries Ltd. in Israel to bring the Fertilome test, the world's first multigene panel test for a woman's reproductive health and fertility, to the Israeli market.

9 Oct 2018

New pre-clinical research shows utility of mRNA platform to treat rare metabolic disorders

An mRNA platform that can express therapeutic levels of protein in liver tissue could be used to treat patients with rare metabolic disorders.

9 Oct 2018

Study suggests novel approach to treating adults with autism spectrum disorder

A team of scientists at Florida Atlantic University has uncovered a brain-signaling pathway that can be pharmacologically manipulated in genetically engineered mice to reverse an autism-related pathway.

8 Oct 2018

Neoadjuvant clinical trial of immune checkpoint blockade for melanoma patients yields high response rate

Combination checkpoint blockade before surgery (neoadjuvant therapy) produced a high response rate among patients with high-risk stage 3 melanoma, with nearly half having no sign of disease at surgery, but a high incidence of side effects caused the trial to be closed early.

8 Oct 2018

Beyond BRCA: Epigenetic Silencing in Breast Cancer

An interview with Professor William Newman, discussing his recent discovery in the field of breast cancer research, and the options that this will provide for women who have a family history of breast cancer but test negative for BRCA1/2 mutations.

8 Oct 2018

Lyra Therapeutics announces presentation of Phase 1 clinical data for LYR-210 in CRS patients

Lyra Therapeutics, Inc., a clinical-stage biotechnology company developing medicines precisely designed to target ear, nose and throat diseases, today announced the presentation of Phase 1 clinical data for the company's lead therapeutic, LYR-210, for chronic rhinosinusitis, a debilitating disease caused by inflammation of the paranasal sinus tissues that affects approximately 27 million people, or 11% of the adult population in the U.S.

8 Oct 2018

Damage to small nerves shown to be cause of chronic pain following knee surgeries

Patients frequently experience severe chronic pain following knee operations. Although the pain is thought to be due to damage to small nerves, it was hitherto impossible to demonstrate this by imaging.

8 Oct 2018

FDA approves expanded use of Gardasil 9 for adults aged 27 to 45 years

The U.S. Food and Drug Administration today approved a supplemental application for Gardasil 9 (Human Papillomavirus (HPV) 9-valent Vaccine, Recombinant) expanding the approved use of the vaccine to include women and men aged 27 through 45 years.

6 Oct 2018

Researchers receive $1.2 million grant to test potential treatment for metastatic breast cancer

A team of Medical University of South Carolina Hollings Cancer Center researchers received a three-year, $1.2 million grant from the U.S. Department of Defens to test a potential therapeutic antibody that could block breast cancer growth with fewer side effects, opening up potential for future drug development.

5 Oct 2018

RNA sequencing method uncovers new insights into biological events in heart disease

Scientists using a powerful new technology that sequences RNA in 20,000 individual cell nuclei have uncovered new insights into biological events in heart disease.

5 Oct 2018

Amputation injury is reflected in bioelectric properties of opposing, undamaged limb

In research that extends knowledge about the physiology of regeneration and wound repair, Tufts University biologists have discovered that amputation of one limb is immediately reflected in the bioelectric properties of the contralateral, or opposing, undamaged limb of developing frogs.

5 Oct 2018

New approach could lead to precise treatments for traumatic brain injury

Traumatic head injury can have widespread effects in the brain, but now scientists can look in real time at how head injury affects thousands of individual cells and genes simultaneously in mice.

5 Oct 2018

Low-dose aspirin use associated with reduced ovarian cancer risk

Taking a low-dose aspirin daily may help women lower their risk of developing ovarian cancer. A new study co-led by Moffitt Cancer Center found that women who reported taking a low-dose aspirin every day had a 23 percent lower risk of ovarian cancer compared to nonaspirin users.

4 Oct 2018

Alnylam announces positive results from Phase 1/2 study of lumasiran for treating primary hyperoxaluria-1

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today updated positive results from its Phase 1/2 clinical study of lumasiran, an investigational, subcutaneously administered RNAi therapeutic targeting glycolate oxidase for the treatment of primary hyperoxaluria type 1.

4 Oct 2018

Vaxart to present new data from Phase 2 Challenge Study of H1 influenza oral tablet vaccine

Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced it will present new data from the Phase 2 Challenge Study of its H1 influenza oral tablet vaccine at IDWeek 2018 in San Francisco on Saturday, October 6, 2018.

4 Oct 2018

Doctors use bacteriophages to treat patient with multi-drug resistant bacterial infection

The married professors were spending their Thanksgiving holiday in Egypt when the husband, Thomas L. Patterson, Ph.D., got very sick very quickly, experiencing fever, nausea and a racing heartbeat. By the time Patterson was accurately diagnosed with a highly multi-drug resistant bacterial infection, he was near death.

4 Oct 2018

Study suggests diet as major contributor for high risk of hypertension in black Americans

New findings suggest that diet is a major contributor for the increased risk of hypertension in black compared to white Americans.

4 Oct 2018

Medrobotics markets its Flex Robotic System for gastroenterology applications in Europe

Medrobotics Corp. today announced the first sale in Europe of their Flex Robotic System for gastroenterology applications.

4 Oct 2018

pH News and Research

Further Reading

Study explores sextortion prevalence behaviors among teens

Antibody Screening Tools; Improving Workflows

Celmatix partners with Oncotest-Teva to bring Fertilome test to Israel

New pre-clinical research shows utility of mRNA platform to treat rare metabolic disorders

Study suggests novel approach to treating adults with autism spectrum disorder

Neoadjuvant clinical trial of immune checkpoint blockade for melanoma patients yields high response rate

Beyond BRCA: Epigenetic Silencing in Breast Cancer

Lyra Therapeutics announces presentation of Phase 1 clinical data for LYR-210 in CRS patients

Damage to small nerves shown to be cause of chronic pain following knee surgeries

FDA approves expanded use of Gardasil 9 for adults aged 27 to 45 years

Researchers receive $1.2 million grant to test potential treatment for metastatic breast cancer

RNA sequencing method uncovers new insights into biological events in heart disease

Amputation injury is reflected in bioelectric properties of opposing, undamaged limb

New approach could lead to precise treatments for traumatic brain injury

Low-dose aspirin use associated with reduced ovarian cancer risk

Alnylam announces positive results from Phase 1/2 study of lumasiran for treating primary hyperoxaluria-1

Vaxart to present new data from Phase 2 Challenge Study of H1 influenza oral tablet vaccine

Doctors use bacteriophages to treat patient with multi-drug resistant bacterial infection

Study suggests diet as major contributor for high risk of hypertension in black Americans

Medrobotics markets its Flex Robotic System for gastroenterology applications in Europe

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo